Detalhe da pesquisa
1.
The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis.
Drug Des Devel Ther;
17: 477-496, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36814892
2.
Exploring the components and mechanisms of Shen-qi-wang-mo granule in the treatment of retinal vein occlusion by UPLC-Triple TOF MS/MS and network pharmacology.
Sci Rep;
13(1): 5330, 2023 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37005436
3.
Simultaneous online SPE-HPLC-MS/MS quantification of gefitinib, osimertinib and icotinib in dried plasma spots: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
J Pharm Biomed Anal;
228: 115275, 2023 May 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36871365
4.
Identification of bicyclol metabolites in rat plasma, urine and feces by UPLC-Q-TOF-MS/MS and evaluation of the efficacy and safety of these metabolites based on network pharmacology and molecular docking combined with toxicity prediction.
J Pharm Biomed Anal;
220: 114947, 2022 Oct 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35985135
5.
Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-ß signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification.
J Ethnopharmacol;
289: 115031, 2022 May 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35091014